GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Total Long-Term Liabilities

BioStem Technologies (BioStem Technologies) Total Long-Term Liabilities : $1.43 Mil (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. BioStem Technologies's Total Long-Term Liabilities for the quarter that ended in Sep. 2023 was $1.43 Mil.


BioStem Technologies Total Long-Term Liabilities Historical Data

The historical data trend for BioStem Technologies's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Total Long-Term Liabilities Chart

BioStem Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 1.20 1.50 1.93 1.09

BioStem Technologies Quarterly Data
Sep15 Dec15 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.09 1.07 1.43

BioStem Technologies Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


BioStem Technologies Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


BioStem Technologies (BioStem Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.

BioStem Technologies (BioStem Technologies) Headlines

From GuruFocus

BioStem Technologies Enters Into a Share Exchange Agreement

By sperokesalga sperokesalga 02-14-2023

Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions

By Stock market mentor Stock market mentor 01-24-2023

BioStem Technologies, Announces Filing of 2020 Quarterly Reports

By Marketwired Marketwired 12-24-2020